AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Tramphia, also known as gazelcomab, is a prescription medication specifically designed for adults suffering from moderately to severely active ulcerative colitis. Many patients using Tramphia have reported significant improvements in their condition, including achieving clinical remission and even endoscopic remission within a year. It is important for patients to consult with their healthcare provider to determine if Tramphia is suitable for managing their UC symptoms, particularly considering the potential for serious allergic reactions and increased infection risk. Patients are advised to undergo testing for infections and tuberculosis before starting treatment to ensure their safety.